|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.21 USD | +1.15% |
|
+4.50% | +13.27% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -9.02x | 4.2x | 4.02x | -7.42x | -6.96x | 2.24B | ||
| 0.58% | 0.66% | 17.29x | 2x | 3.79x | 10.17x | 11.26x | 67.96B | ||
| 0.59% | 0.6% | 27.02x | 4.05x | 5.55x | 16.28x | 20.3x | 54.4B | ||
| 3.27% | 3.36% | -46.91x | 2.56x | 3.29x | 9.71x | 11.33x | 41.74B | ||
| -.--% | -.--% | 32.87x | 6.59x | 11.12x | 21.25x | 24.77x | 40.63B | ||
| -.--% | -.--% | -8.83x | 5.36x | 12.88x | -7.91x | -7.47x | 30.38B | ||
| -.--% | -.--% | 30.31x | 1.57x | 3.47x | 10.96x | 12.8x | 29.37B | ||
| -.--% | -.--% | 17.2x | 3.44x | 3.3x | 10.01x | 9.82x | 23.68B | ||
| -.--% | 0.05% | 57.92x | 5.51x | 6.05x | 41.38x | 40.23x | 19.15B | ||
| -.--% | -.--% | -41.11x | -7.19x | 19.11x | -58.05x | -60.82x | 17.68B | ||
| -.--% | -.--% | 26.74x | 3.74x | 5.48x | 14.72x | 20.33x | 17.14B | ||
| -.--% | -.--% | -125.28x | 13185.91x | 12.87x | -114.19x | -127.16x | 12.81B | ||
| -.--% | -.--% | 17.03x | - | 3.62x | 13.26x | 15.89x | 11.59B | ||
| -.--% | -.--% | 48.15x | - | - | - | - | 10.94B | ||
| 0.17% | 0.18% | 54.89x | 22.38x | 33.22x | 46.98x | 48.45x | 10.64B | ||
| 2.84% | 3.28% | 11.83x | 1.03x | 1.8x | 7.28x | 9.75x | 6.21B | ||
| 0.38% | 0.45% | 27x | - | 7.22x | 19.16x | 22.88x | 5.5B | ||
| 1.67% | 1.85% | 13.54x | 1.24x | 2.33x | 6.02x | 7.29x | 5.42B | ||
| Average | 0.53% | 0.58% | 8.37x | 882.83x | 8.18x | 2.33x | 3.10x | 22.64B | |
| Weighted average by Cap. | 0.59% | 0.62% | 9.50x | 448.67x | 7.31x | 6.41x | 7.70x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















